Tokyo, Sept. 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059170) titled 'Registry of the renal rehabilitation in patients with chronic kidney disease' on Sept. 25.
Study Type:
Observational
Primary Sponsor:
Institute - The Japanese Society of Renal Rehabilitation
Condition:
Condition - Chronic kidney disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - With the progression of chronic kidney disease and the aging of the population, the number of chronic kidney disease patients with frailty and sarcopenia is increasing year by year, and the importance of renal rehabilitation is recognized. In 2022, the Japanese government started a new insurance coverage for exercise therapy for dialysis patients. However, its effectiveness and safety have not been sufficiently investigated. Therefore, we aimed to create a registry of renal rehabilitation for chronic kidney disease patients and to evaluate its effectiveness and safety from multiple perspectives.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Chronic kidney disease patients who already started or will be started renal rehabilitation
Key exclusion criteria - Patients who are bedridden, have limb defects, have advanced dementia, or are otherwise deemed inappropriate by their attending physician
Target Size - 400
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 08 Month 13 Day
Date of IRB - 2025 Year 08 Month 21 Day
Anticipated trial start date - 2025 Year 08 Month 21 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067672
Disclaimer: Curated by HT Syndication.
